Catherine Olivier, PhD
Affiliations: | 2006-2013 | Faculty of Medicine | Université de Montréal, Montreal |
2013-2019 | Fonds de recherche du Quebec | ||
2019- | INESSS |
Area:
research ethics, responsible conduct of researchWebsite:
https://www.linkedin.com/in/catherine-olivier-3685784bGoogle:
"Catherine Olivier"Cross-listing: Bioethics Tree
Parents
Sign in to add mentorBryn Williams-Jones | grad student | 2006-2013 | Université de Montréal, Montreal | |
(PhD) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Racine E, Ji S, Badro V, et al. (2024) Living ethics: a stance and its implications in health ethics. Medicine, Health Care, and Philosophy |
Racine E, D'Anjou B, Dallaire C, et al. (2023) Developing a living lab in ethics: Initial issues and observations. Bioethics |
Durocher E, Chung R, Rochon C, et al. (2017) Ethical questions identified in a study of local and expatriate responders' perspectives of vulnerability in the 2010 Haiti earthquake. Journal of Medical Ethics |
Olivier C, Hunt MR, Ridde V. (2016) NGO–researcher partnerships in global health research: benefits, challenges, and approaches that promote success Development in Practice. 26: 444-455 |
Olivier C, Williams-Jones B. (2014) Global pharmacogenomics: where is the research taking us? Global Public Health. 9: 312-24 |
Williams-Jones B, Olivier C, Smith E. (2014) Governing 'dual-use' research in Canada: A policy review Science and Public Policy. 41: 76-93 |
Olivier C, Williams-Jones B. (2011) Pharmacogenomic technologies: a necessary "luxury" for better global public health? Globalization and Health. 7: 30 |
Olivier C, Williams-Jones B, Doizé B, et al. (2010) Containing global antibiotic resistance: Ethical drug promotion in the developing world Antimicrobial Resistance in Developing Countries. 505-524 |
Olivier C, Williams-Jones B, Godard B, et al. (2008) Personalized medicine, bioethics and social responsibilities: Re-thinking the pharmaceutical industry to remedy inequities in patient care and international health Current Pharmacogenomics and Personalized Medicine. 6: 108-120 |